Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04928872 · ClinicalTrials.gov registry record
Macronutrient Distribution and Plasma Metabolites to Model Meals Composition
A clinical trial, sponsored by Texas A&M University.
- Completed
- Registry status
- 23
- Enrollment target
NCT04928872: Completed study, sponsored by Texas A&M University.
NCT04928872 is a clinical trial that has completed, run by Texas A&M University. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04928872 has completed, sponsored by Texas A&M University.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
Continuous glucose monitors (CGMs) measure plasma glucose concentration continually and thus they are a key tool in the management of diabetes, including type 2 diabetes (T2D). A key factor in diabetes management is a reduction of dietary carbohydrates (CHO) and/or exchanging high glycemic index (GI) CHO with low GI CHO. However, the protein and fat content of the meal can have a significant impact on the glucose readings obtained from a CGM as there is no enough data available on their sensitivity during meals.
Primary Outcome
Participants consume 9 predefined meals in the fasted state with macronutrient composition reflecting common meals in the US diet. One meal is consumed during one study visit with a total of 9 visits. A baseline sample is collected followed by an intake of one meal during one study visit. Blood samples (in the 15-and 30-minutes interval) are collected for 8 hours after a meal intake. Collected plasma will be used for amino acid analysis. Statistical models will be used to predict plasma amino ac
Interventions
- COMBINATION_PRODUCT Predefined meal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2018-06-20 |
| Est. Completion | 2020-01-14 |
What the finished NCT04928872 record still lists
NCT04928872 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Predefined meal is the first listed.
NCT04928872 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04928872 about?
NCT04928872 is a clinical study titled "Macronutrient Distribution and Plasma Metabolites to Model Meals Composition". Continuous glucose monitors (CGMs) measure plasma glucose concentration continually and thus they are a key tool in the management of diabetes, including type 2 diabetes (T2D). A key factor in diabetes management is a reduction of dietary carbohydrates (CHO) and/or exchanging high glycemic index (GI...
What is the current status of trial NCT04928872?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2018-06-20. Estimated completion is 2020-01-14.
What interventions are being tested in trial NCT04928872?
The interventions under investigation include: Predefined meal (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04928872?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI